Total Payments
$1,332
2024 Payments
$44.62
Companies
20
Transactions
75
Medicare Patients
8,397
Medicare Billing
$874,305
Payment Breakdown by Category
Food & Beverage$1,133 (85.1%)
Education$198.62 (14.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,133 | 67 | 85.1% |
| Education | $198.62 | 8 | 14.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $423.51 | 23 | $0 (2023) |
| Astellas Pharma US Inc | $160.65 | 10 | $0 (2022) |
| ABBVIE INC. | $144.66 | 6 | $0 (2023) |
| Coloplast Corp | $128.28 | 9 | $0 (2022) |
| MEDIVATION INC. | $73.28 | 4 | $0 (2017) |
| Janssen Biotech, Inc. | $66.16 | 3 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $42.83 | 2 | $0 (2024) |
| Allergan, Inc. | $36.99 | 2 | $0 (2021) |
| Rochester Medical Corporation | $36.73 | 3 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $31.74 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.62 | 2 | Telix Pharmaceuticals ($22.59) |
| 2023 | $103.72 | 5 | PFIZER INC. ($38.07) |
| 2022 | $190.89 | 10 | PFIZER INC. ($73.22) |
| 2021 | $143.66 | 8 | PFIZER INC. ($50.84) |
| 2020 | $74.67 | 4 | AbbVie Inc. ($22.95) |
| 2019 | $281.57 | 18 | PFIZER INC. ($66.32) |
| 2018 | $187.44 | 12 | PFIZER INC. ($49.16) |
| 2017 | $305.11 | 16 | PFIZER INC. ($145.90) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: UROLOGY | ||||||
| 06/15/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/28/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/21/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Urology | ||||||
| 02/13/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/07/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/11/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HORMONE THERAPY | ||||||
| 08/03/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Oncology | ||||||
| 06/30/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/30/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Continence Care | ||||||
| 04/15/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 02/11/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Oncology | ||||||
| 10/19/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/08/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/03/2021 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Medical Systems | ||||||
| 06/29/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: ONCOLOGY | ||||||
| 01/14/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Continence Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,762 | 2,862 | $615,786 | $173,706 |
| 2022 | 26 | 2,266 | 3,836 | $830,501 | $237,724 |
| 2021 | 23 | 2,185 | 3,546 | $772,402 | $240,034 |
| 2020 | 29 | 2,184 | 3,614 | $845,968 | $222,842 |
Total Patients
8,397
Total Services
13,858
Medicare Billing
$874,305
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3315 | Injection, triptorelin pamoate, 3.75 mg | Office | 2023 | 13 | 117 | $95,850 | $34,520 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 402 | 561 | $127,347 | $33,545 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 310 | $103,850 | $28,159 | 27.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 123 | 148 | $64,370 | $27,686 | 43.0% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 14 | 110 | $27,500 | $10,543 | 38.3% |
| 52353 | Crushing of stone of ureter using an endoscope | Facility | 2023 | 20 | 23 | $27,922 | $7,562 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 38 | $23,712 | $5,243 | 22.1% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 15 | 15 | $13,410 | $3,413 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 23 | $10,281 | $3,257 | 31.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 26 | 33 | $33,000 | $3,046 | 9.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 493 | 841 | $16,820 | $2,845 | 16.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 56 | $5,320 | $2,752 | 51.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 215 | 322 | $19,642 | $2,536 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,288 | $2,332 | 19.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 23 | 24 | $10,392 | $2,212 | 21.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 47 | $4,747 | $1,238 | 26.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 45 | 67 | $4,288 | $1,190 | 27.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 36 | 52 | $2,964 | $1,021 | 34.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 21 | 22 | $11,000 | $518.60 | 4.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 16 | 29 | $1,083 | $89.47 | 8.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 486 | 730 | $165,710 | $46,599 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 262 | 429 | $143,715 | $40,924 | 28.5% |
| J3315 | Injection, triptorelin pamoate, 3.75 mg | Office | 2022 | 18 | 129 | $96,750 | $35,599 | 36.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 137 | 166 | $65,238 | $32,715 | 50.1% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2022 | 17 | 140 | $35,000 | $13,508 | 38.6% |
About Dr. Peter Levesque, MD
Dr. Peter Levesque, MD is a Urology healthcare provider based in Taunton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235163783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Levesque, MD has received a total of $1,332 in payments from pharmaceutical and medical device companies, with $44.62 received in 2024. These payments were reported across 75 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,133).
As a Medicare-enrolled provider, Levesque has provided services to 8,397 Medicare beneficiaries, totaling 13,858 services with total Medicare billing of $874,305. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Taunton, MA
- Active Since 07/10/2006
- Last Updated 10/20/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235163783
Products in Payments
- XTANDI (Drug) $500.75
- LUPRON DEPOT (Drug) $108.73
- SPEEDICATH (Device) $86.65
- Erleada (Drug) $78.86
- MYRBETRIQ (Drug) $67.27
- GEMTESA (Drug) $42.83
- BOTOX (Biological) $36.99
- Myrbetriq (Drug) $34.81
- Xtandi (Drug) $28.95
- SpeediCath (Device) $28.66
- UroLift (Device) $24.84
- Noctiva (Drug) $23.24
- ILLUCCIX (Drug) $22.59
- NOCDURNA (Drug) $22.11
- Lupron Depot (Drug) $20.10
- ORGOVYX (Drug) $19.86
- Natesto (Drug) $19.62
- ERLEADA (Drug) $19.04
- VIAGRA (Drug) $16.07
- INTERSTIM (Device) $15.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.